1887

Abstract

The EBNA-LP protein (also known as EBNA-5) of Epstein—Barr virus (EBV) has been reported previously to colocalize in the nuclei of cells with the pRb protein and to bind to pRb and to the p53 protein, suggesting a role for EBNA-LP in modulation of the function of these proteins. Here we test in transfection assays whether EBNA-LP expression has any functional consequence for repression of E2F-1 activity by pRb or p107 or for activation of transcription by the p53 protein. No significant effect could be found, although the assay systems were sensitive to the established effects of simian virus 40 large T antigen and human papillomavirus type 16 E6 protein. There was very effective repression of GAL4/E2F-1 transactivation by p107, consistent with earlier reports and indicating that p107 can interact with the E2F-1 transactivation domain, even though p107 has been reported to bind specifically to E2F complexes containing E2F-4. The results indicate that, if the associations of EBNA-LP with pRB and p53 are physiologically relevant, they most likely affect other functions of these proteins or modulate their gene regulatory functions in ways that cannot be detected by transfection into cycling transformed cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-9-2141
1995-09-01
2022-10-02
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/9/JV0760092141.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-9-2141&mimeType=html&fmt=ahah

References

  1. Allan G. J., Inman G. J., Parker B. D., Rowe D. T., Farrell P. J. 1992; Cell growth effects of Epstein-Barr virus leader protein. Journal of General Virology 73:1547–1551
    [Google Scholar]
  2. Allday M. J., Sinclair A. J., Parker G., Crawford D. H., Farrell P. J. 1995; Epstein-Barr virus efficiently immortalises human B cells without neutralising the function of p53. EMBO Journal 14:1382–1391
    [Google Scholar]
  3. Bargonetti J., Reynisdottir I., Friedman P. N., Prives C. 1992; Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes and Development 6:1886–1898
    [Google Scholar]
  4. Beijersbergen R. L., Hijmans E. M., Zhu L., Bernards R. 1994; Interaction of c-myc with the pRb-related protein pi07 results in inhibition of c-myc mediated transactivation. EMBO Journal 13:4080–4087
    [Google Scholar]
  5. Ben-Bassat H., Goldblum N., Mitrani S., Goldblum T., Yoffey J. M., Cohen M. M., Bentwich Z., Ramot B., Klein E., Klein G. 1977; Establishment in continuous culture of a new type of lymphocyte from a ‘Burkitt like’ malignant lymphoma (line DG-75). International Journal of Cancer 19:27–33
    [Google Scholar]
  6. Buschle M., Brenner M. K., Chen I. S. Y., Drexter S., Gignac S. M., Rooney C. M. 1990; Transfection and gene expression in normal and malignant primary B lymphocytes. Journal of Immunological Methods 133:77–86
    [Google Scholar]
  7. Chen L., Nishinaka T., Kwan K., Kiatbayashi I., Yokoyama K., Fu Y. H.-F., Grunwald S., Chiu R. 1994; The retinoblastoma gene product RB stimulates Spl -mediate transcription by liberating Spl from a negative regulator. Molecular and Cellular Biology 14:4380–4389
    [Google Scholar]
  8. Cress W. D., Johnson D. G., Nevins J. R. 1993; A genetic analysis of the E2F1 gene distinguishes regulation by Rb, pl07, and adenovirus E4. Molecular and Cellular Biology 13:6314–6325
    [Google Scholar]
  9. Crook T., Fisher C., Masterson P. J., Vousden K. H. 1994a; Modulation of transcriptional regulatory properties of p53 by HPV E6. Oncogene 9:1225–1230
    [Google Scholar]
  10. Crook T., Marston N. J., Sara E. A., Vousden K. H. 1994b; Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79:959–962
    [Google Scholar]
  11. Dynlacht B. D., Flores O., Lees J., Harlow E. 1994; Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes and Development 8:1772–1786
    [Google Scholar]
  12. Dyson N., Dembski M., Fattaey A., Ngwu C., Ewen M., Helin K. 1993; Analysis of pl07-associated proteins: pl07 associates with a form of E2F that differs from pRB-associated E2F-1. Journal of Virology 67:7641–7647
    [Google Scholar]
  13. Ewen M. E., Xing Y., Lawrence J. B., Livingston D. M. 1991; Molecular cloning, chromosomal mapping, and expression of the cDNA for pl07, a retinoblastoma gene product-related protein. Cell 66:1155–1164
    [Google Scholar]
  14. Farmer G., Bargonetti J., Zhu H., Friedman P., Prywes R., Prives C. 1992; Wild-type p53 activates transcription in vitro. Nature 358:83–86
    [Google Scholar]
  15. Farrell P. J. 1995; Epstein-Barr virus immortalising genes. Trends in Microbiology 3:105–109
    [Google Scholar]
  16. Farrell P. J., Allan G. J., Shanahan F., Vousden K. H., Crook T. 1991; p53 is frequently mutated in Burkitt’s lymphoma cell lines. EMBO Journal 10:2879–2887
    [Google Scholar]
  17. Finke J., Rowe M., Kallin B., Ernberg I., Rosen A., Dillner J., Klein G. 1987; Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt’s lymphoma and lymphoblastoid cell lines. Journal of Virology 61:3870–3878
    [Google Scholar]
  18. Flemington E. K., Speck S. H., Kaelin W. G. 1993; E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proceedings of the National Academy of Sciences, USA 90:6914–6918
    [Google Scholar]
  19. Ginsberg D., Vairo G., Chittenden T., Xiao Z., Xu G., Wydner K. L., Decaprio J. A., Lawrence J. B., Livingston D. M. 1994; E2F-4, a new member of the E2F transcription factor family, interacts with pl07. Genes and Development 8:2665–2679
    [Google Scholar]
  20. Goodrich D. W., Lee W. H. 1993; Molecular characterization of the retinoblastoma susceptibility gene. Biochimica et Biophysica Acta 1155:43–61
    [Google Scholar]
  21. Grieves R., O’Hare P. 1989; Separation of requirements for protein-DNA complex assembly from those for functional activity in the herpes simplex virus regulatory protein Vmw65. Journal of Virology 63:1641–1650
    [Google Scholar]
  22. Hagemeier C., Bannister A. J., Cook A., Kouzarides T. 1993; The activation domain of transcription factor PU.l binds theretinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proceedings of the National Academy of Sciences, USA 90:1580–1584
    [Google Scholar]
  23. Hammerschmidt W., Sugden B. 1989; Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340:393–397
    [Google Scholar]
  24. Helin K., Lees J. A., Vidal M., Dyson N., Harlow E., Fattaey A. 1992; A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337–350
    [Google Scholar]
  25. Helin K., Harlow E., Fattaey A. 1993; Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Molecular and Cellular Biology 13:6501–6508
    [Google Scholar]
  26. Inman G. 1995 Epstein-Barr virus leader protein PhD thesis University of London; UK.:
    [Google Scholar]
  27. Ivey-Hoyle M., Conroy R., Huber H. E., Goodhart P. J., Oliff A., Heimbrook D. C. 1993; Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Molecular and Cellular Biology 13:7802–7812
    [Google Scholar]
  28. Jiang W. Q., Szekely L., Wendel-Hansen V., Ringertz N., Klein G., Rosen A. 1991; Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Experimental Cell Research 197:314–318
    [Google Scholar]
  29. Kaelin W. G., Krek W., Sellers W. R., Decaprio J. A., Ajchenbaum F., Fuchs C. S., Chittenden T., Li Y., Farnham P. J., Blanar M. A., Livingston D. M., Flemington E. K. 1992; Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351–364
    [Google Scholar]
  30. Kern S. E., Pietenpol J. A., Thiagalingam S., Seymour A., Kinzler K. W., Vogelstein B. 1992; Oncogenic forms of p53 inhibit p53-reguiated gene expression. Science 256:827–830
    [Google Scholar]
  31. Kim S. J., Lee H. D., Robbins P. D., Busam K., Sporn M. B., Roberts A. B. 1991; Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. Proceedings of the National Academy of Science, USA 88:3052–3056
    [Google Scholar]
  32. Kim S. J., Wagner S., Liu F., O’Reilly M. A., Robbins P. D., Green M. R. 1992; Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358:331–334
    [Google Scholar]
  33. Lam E., La Thangue N. B. 1994; DP and E2F proteins: coordinating transcription with cell cycle progression. Current Opinion in Cell. Biology 6:859–866
    [Google Scholar]
  34. La Thangue N. B. 1994; DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends in Biochemical Sciences 19:108–114
    [Google Scholar]
  35. Lechner M. S., Mack D. H., Finicle A. B., Crook T., Vousden K.H., Laimins L. A. 1992; Human papillomavirus E6 proteins bind p53 in vivo and abrogates p53-mediated repression of transcription. EMBO Journal 11:3045–3052
    [Google Scholar]
  36. Lees J. A., Saito M., Vidal M., Valentine M., Look T., Harlow E., Dyson N., Helin K. 1993; The retinoblastoma protein binds to a family of E2F transcription factors. Molecular and Cellular Biology 13:7813–7825
    [Google Scholar]
  37. Mannick J. B., Cohen J., Birkenbach M., Marchini A., Kieff E. 1991; The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. Journal of Virology 65:6826–6837
    [Google Scholar]
  38. Mietz J. A., Unger T., Huibregtse J. M., Howley P. M. 1992; The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO Journal 11:5013–5020
    [Google Scholar]
  39. Miller J. H. 1972 Experiments in Molecular Genetics p 355 New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  40. Momand J., Zambetti G. P., Olson D. C., George D., Levine A. J. 1992; The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245
    [Google Scholar]
  41. Moran E. 1993; DNA tumor virus transforming proteins and the cell cycle. Current Opinion in Genetics and Development 3:63–70
    [Google Scholar]
  42. Morgenstern J. P., Land H. 1990; A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Research 18:1068
    [Google Scholar]
  43. Picksley S. M., Lane D. P. 1994; p53 and Rb: their cellular roles. Current Opinion in Cell. Biology 6:853–858
    [Google Scholar]
  44. Qin X., Chittenden T., Livingston D. M., Kaelin W. G. 1992; Identification of a growth suppression domain within the retinoblastoma gene product. Genes and Development 6:953–964
    [Google Scholar]
  45. Schwarz J. K., Devoto S. H., Smith E. J., Chellappan S. P., Jakoi L., Nevins J. R. 1993; Interactions of the pl07 and Rb proteins with E2F during the cell proliferation response. EMBO Journal 12:1013–1020
    [Google Scholar]
  46. Segawa K., Minowa A., Sugasawa K., Takano T., Hanaoka F. 1993; Abrogation of p53-mediated transactivation by SV40 large T antigen. Oncogene 8:543–548
    [Google Scholar]
  47. Shan B., Chang C. Y., Jones D., Lee W. H. 1994; The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Molecular and Cellular Biology 14:299–309
    [Google Scholar]
  48. Sherr C. J. 1994; G1 phase progression: cycling on cue. Cell 79:551–555
    [Google Scholar]
  49. Sinclair A. J., Palmero L., Peters G., Farrell P. J. 1994; EBNA-2 and EBNA-LP cooperate to cause GO to G1 transition during immortalisation of resting human B lymphocytes by Epstein-Barr virus. EMBO Journal 13:3321–3328
    [Google Scholar]
  50. Sleigh M. J. 1986; A non-chromatographic assay for expression of the chloramphenicol acetyl transferase gene in eukaryotic cells. Analytical Biochemistry 156:251–256
    [Google Scholar]
  51. Szekely L., Selivanova G., Magnusson K. P., Klein G., Wiman K. G. 1993; EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proceedings of the National Academy of Sciences, USA 90:5455–5459
    [Google Scholar]
  52. Takada K., Ono Y. 1989; Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. Journal of Virology 63:445–449
    [Google Scholar]
  53. Vousden K. H., Crook T., Farrell P. J. 1993; Biological activities of p53 mutants in Burkitt‘s lymphoma cells. Journal of General Virology 74:803–810
    [Google Scholar]
  54. Wang C. Y., Petryniak B., Thompson C. B., Kaelin W. G., Leiden J. M. 1993; Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260:1330–1335
    [Google Scholar]
  55. Watson R. J., Robinson C., Lam E. W. 1993; Transcription regulation by murine B-myb is distinct from that by c-myb. Nucleic Acids Research 21:267–272
    [Google Scholar]
  56. Welch P. J., Wang J. Y. 1993; A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779–790
    [Google Scholar]
  57. Yew P. R., Berk A. J. 1992; Inhibition of p53 transactivation required for transformation by adenovirus early IB protein. Nature 357:82–85
    [Google Scholar]
  58. Yew P. R., Liu X., Berk A. J. 1994; Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes and Development 8:190–202
    [Google Scholar]
  59. Zamanian M., La Thangue N. B. 1993; Transcriptional repression by the Rb-related protein pi07. Molecular and Cellular Biology 4:389–396
    [Google Scholar]
  60. Zhu L., van den Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D., Dyson N., Harlow E. 1993; Inhibition of cell proliferation by pl07, a relative of the retinoblastoma protein. Genes and Development 7:1111–1125
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-9-2141
Loading
/content/journal/jgv/10.1099/0022-1317-76-9-2141
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error